跳至主要内容
临床试验/DRKS00032799
DRKS00032799招募中不适用

A prospective, multicenter, single-arm follow-up study to systematically record motor symptoms and associated quality of life in idiopathic Parkinson's patients - SymptoEase

EVER Pharma GmbH0 个研究点目标入组 100 人开始时间: 2023年10月5日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Idiopathic Parkinson's disease
  • - Disease in moderate to severe phase (Hoehn & Yahr scale value: 2.0 to 4.0)
  • - Motor fluctuations (with at least two hours per day in the OFF phase)
  • - Voluntary participation in the study
  • - Signed declaration of consent including data protection declaration
  • - Signed confidentiality agreement
  • - Signed STAT-ON® privacy policy

排除标准

  • - Hoehn & Yahr scale value greater than 4.0
  • - Wheelchair required
  • - Participation in another study
  • - Acute illness affecting the study
  • - Psychiatric or other cognitive impairment that does not allow participation in the study (Mini-Mental Status Test (MMSE) points less than 24)

研究者

发起方
EVER Pharma GmbH

相似试验